As of January 22, 2025, X4 Pharmaceuticals (XFOR) has a market cap of $83.209 million USD. According to our data, X4 Pharmaceuticals is ranked No.7829 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $83.21 M |
-33.53%
|
Dec 31, 2024 | $0.13 B |
-12.51%
|
Dec 29, 2023 | $0.14 B |
-15.51%
|
Dec 30, 2022 | $0.17 B |
-56.64%
|
Dec 31, 2021 | $0.39 B |
-64.39%
|
Dec 31, 2020 | $1.10 B |
-39.91%
|
Dec 31, 2019 | $1.82 B |
-23.13%
|
Dec 31, 2018 | $2.37 B |
-81.82%
|
Dec 29, 2017 | $13.06 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
BioCryst Pharmaceuticals
BCRX
|
$1.58 B |
0.000 M
|
USA
|
Kiniksa Pharmaceuticals
KNSA
|
$1.39 B |
0.588 B
|
|
Apellis Pharmaceuticals
APLS
|
$3.78 B |
-0.000 M
|
USA
|
Allakos
ALLK
|
$0.10 B |
0.000 M
|
USA
|
Immunovant
IMVT
|
$3.93 B |
-0.000 M
|
USA
|
Alector
ALEC
|
$0.17 B |
0.000 M
|
USA
|
Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Market Cap | = | XFOR Stock Price | * | XFOR Shares Outstanding |
= | $0.49 | * | 0.17 B | |
= | $83.21 M |